project . 2021 - 2024 . Not started

ITHACA

Digital Twin Technology to Predict Individual Response to Pharmacological Treatments in Ovarian Cancer
Open Access mandate for Publications European Commission
  • Funder: European CommissionProject code: 883172 Call for proposal: H2020-MSCA-IF-2019
  • Funded under: H2020 | MSCA-IF-GF Overall Budget: 257,210 EURFunder Contribution: 257,210 EUR
  • Status: Not started
  • Start Date
    01 Sep 2021
    End Date
    31 Aug 2024
  • Detailed project information (CORDIS)
  • Open Access mandate
    Research Data: No
Description
Personalised medicine (PM) is a novel approach to medical care that customises each treatment not just to the disease but also to the patient. While the advantages of this framework are widely recognised and its development is acknowledged as a fundamental societal challenge by the H2020 program, clinical applications are still limited, due to the increased complexity and costs, with respect to the current standard of care. ITHACA aims at developing an innovative PM toolkit that, relying on an advanced computational simulator, innovative in-vitro techniques and standard clinical data could provide an efficient and ethical framework for the screening of different...
Partners
Description
Personalised medicine (PM) is a novel approach to medical care that customises each treatment not just to the disease but also to the patient. While the advantages of this framework are widely recognised and its development is acknowledged as a fundamental societal challenge by the H2020 program, clinical applications are still limited, due to the increased complexity and costs, with respect to the current standard of care. ITHACA aims at developing an innovative PM toolkit that, relying on an advanced computational simulator, innovative in-vitro techniques and standard clinical data could provide an efficient and ethical framework for the screening of different...
Partners
Any information missing or wrong?Report an Issue